Navegar por autor "Miralles Alvarez, María Celia"

Changes in patient-reported outcomes during the SENSE Trial: First-line treatment with 2 NRTIs plus etravirine or efavirenz for 48 weeks

2011- Miralles Alvarez, María Celia

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

2012- Aguilera Guirao, Antonio; Miralles Alvarez, María Celia; Ocampo Hermida, Antonio; Morano Amado, Luis

¿Cómo está afectando la aplicación del nuevo marco legal sanitario a la asistencia de los inmigrantes infectados por el VIH en situación irregular en España?

2015- Miralles Alvarez, María Celia

Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (Actualización enero 2014)

2014- Miralles Alvarez, María Celia

Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

2015- Mariño Callejo, Ana Isabel; Miralles Alvarez, María Celia; Ocampo Hermida, Antonio; Antela López, Antonio

Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A random

2015- Miralles Alvarez, María Celia; Ocampo Hermida, Antonio

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014)

2014- Miralles Alvarez, María Celia; Antela López, Antonio

High lifetime risk of cardiovascular disease vs low 10-year Framingham risk score in HIV-infected subjects under ART in Spain: the Coronator study

2012- Miralles Alvarez, María Celia

HIV-2 and HTLV-1 infections in Spain, a non-endemic region

2014- Aguilera Guirao, Antonio; Miralles Alvarez, María Celia; García Costa, Juan; Poveda López, Eva

Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C

2011- Castro Iglesias, Angeles; Miralles Alvarez, María Celia; Ocampo Hermida, Antonio

Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens

2012- Mariño Callejo, Ana Isabel; Miralles Alvarez, María Celia

Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe

2015- Álvarez Díaz, Hortensia; Mariño Callejo, Ana Isabel; Ordoñez Barrosa, Patricia; Castro Iglesias, Angeles; Miralles Alvarez, María Celia; [et al.]

Resumen ejecutivo del documento de consenso sobre el manejo de la patología renal en pacientes con infección por el virus de la inmunodeficiencia humana

2014- Miralles Alvarez, María Celia

The need for data on women living with HIV in Europe

2013- Miralles Alvarez, María Celia

The perico trial: A multicenter randomized controled trial comparing high ribavirin (RBV) induction vs standard RBV dosing in the treatment of chronic hepatitis C in HIV-coinfected patients

2011- Miralles Alvarez, María Celia; Morano Amado, Luis

The SHE programme: a European initiative to improve the care of women living with HIV

2012- Miralles Alvarez, María Celia

What do we know about the situation of women living with HIV in Europe?

2013- Miralles Alvarez, María Celia

Repositorio digital RUNA

Navegar por autor "Miralles Alvarez, María Celia"

Changes in patient-reported outcomes during the SENSE Trial: First-line treatment with 2 NRTIs plus etravirine or efavirenz for 48 weeks ﻿

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy ﻿

¿Cómo está afectando la aplicación del nuevo marco legal sanitario a la asistencia de los inmigrantes infectados por el VIH en situación irregular en España? ﻿

Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (Actualización enero 2014) ﻿

Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial ﻿

Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A random ﻿

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014) ﻿

High lifetime risk of cardiovascular disease vs low 10-year Framingham risk score in HIV-infected subjects under ART in Spain: the Coronator study ﻿

HIV-2 and HTLV-1 infections in Spain, a non-endemic region ﻿

Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C ﻿

Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens ﻿

Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe ﻿

Resumen ejecutivo del documento de consenso sobre el manejo de la patología renal en pacientes con infección por el virus de la inmunodeficiencia humana ﻿

The need for data on women living with HIV in Europe ﻿

The perico trial: A multicenter randomized controled trial comparing high ribavirin (RBV) induction vs standard RBV dosing in the treatment of chronic hepatitis C in HIV-coinfected patients ﻿

The SHE programme: a European initiative to improve the care of women living with HIV ﻿

What do we know about the situation of women living with HIV in Europe? ﻿

Changes in patient-reported outcomes during the SENSE Trial: First-line treatment with 2 NRTIs plus etravirine or efavirenz for 48 weeks

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

¿Cómo está afectando la aplicación del nuevo marco legal sanitario a la asistencia de los inmigrantes infectados por el VIH en situación irregular en España?

Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (Actualización enero 2014)

Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A random

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014)

High lifetime risk of cardiovascular disease vs low 10-year Framingham risk score in HIV-infected subjects under ART in Spain: the Coronator study

HIV-2 and HTLV-1 infections in Spain, a non-endemic region

Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C

Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens

Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe

Resumen ejecutivo del documento de consenso sobre el manejo de la patología renal en pacientes con infección por el virus de la inmunodeficiencia humana

The need for data on women living with HIV in Europe

The perico trial: A multicenter randomized controled trial comparing high ribavirin (RBV) induction vs standard RBV dosing in the treatment of chronic hepatitis C in HIV-coinfected patients

The SHE programme: a European initiative to improve the care of women living with HIV

What do we know about the situation of women living with HIV in Europe?